Humana Shares Drop as Lowered Reported Profit Forecast Overshadows Q1 EPS Beat
summarizeSummary
Humana reported an adjusted quarterly earnings per share (EPS) of $10.31, surpassing analyst estimates of $10.19, driven by lower-than-expected medical service spending. However, the company's shares fell 4.45% pre-bell as it reaffirmed its annual adjusted profit forecast of at least $9, but *lowered* its reported profit forecast to "at least $8.36" from "at least $8.89". This revised reported outlook anticipates a year-over-year decline, primarily attributed to the impact of Medicare Advantage Star Ratings. The mixed guidance, particularly the reduction in reported profit expectations, is driving the negative market reaction despite the adjusted EPS beat. Traders will be watching for further details on the Star Ratings impact and future guidance.
في وقت هذا الإعلان، كان HUM يتداول عند ٢١٣٫٤٤ US$ في NYSE ضمن قطاع Life Sciences، مع قيمة سوقية تقارب ٢٧٫٦ مليار US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ١٦٣٫١١ US$ و٣١٥٫٣٥ US$. تم تقييم هذا الخبر على أنه ذو معنويات سوقية سلبية وبدرجة أهمية ٨ من 10. المصدر: Reuters.